Durect corp

Financial Times Close. Search the FT Search.

DURECT harnesses epigenetic modulation to treat serious and life-threatening conditions, including acute organ injury and cancer. Many types of acute organ injuries and cancers are associated with dysregulation of the epigenome, such as DNA methylation. There is vast potential for epigenetic therapies to address the underlying pathophysiology by mitigating epigenomic dysregulation and helping to improve cellular function or suppress tumor growth. Join our highly experienced, talented, and collaborative team as we strive to improve the course of human medicine with novel epigenetic therapies. Brown, President and Chief. Unlocking the potential of epigenetic therapeutics to revolutionize medicine.

Durect corp

.

Show more World link World.

.

Brown , D. We look forward to entering discussions with the U. We also plan to discuss the design of a potential registrational Phase 3 trial using mortality as the primary endpoint. Current treatment with steroids has only marginal short-term benefits and no effect on longer term mortality. In this environment, the results of the current study demonstrating survival benefit are exciting and provide hope for many patients with this condition. Earnings Conference Call We will host a conference call and webcast today at p. Pacific Time to discuss the third quarter results and provide a corporate update:. Monday, November 13 p.

Durect corp

Brown , D. In conjunction with teams of experienced chemists and biologists, our research and development team have designed new chemical entities NCE that are now in preclinical development for multiple oncology indications. With this achievement, DURECT is advancing its mission to be a global leader in the emerging field of epigenetic medicine.

Best vietnamese restaurants near me

Scroll to Top. These cookies will be stored in your browser only with your consent. You can manage and withdraw your consent at any time using our cookie consent tool found here in Cookie Settings. Make up to three selections, then save. The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. Unlocking the potential of epigenetic therapeutics to revolutionize medicine. Show more Companies link Companies. Use our equities screener to discover other potential opportunities. Show more World link World. Show more Personal Finance link Personal Finance. The cookies is used to store the user consent for the cookies in the category "Necessary". Clinical Trials. Partner with us.

The pre-funded warrants and the accompanying warrants will be immediately exercisable. The pre-funded warrants do not expire and the accompanying warrants will expire five years from the date of issuance. The closing of the Offering is expected to occur on or about February 8, , subject to customary closing conditions.

Add to Your Portfolio New portfolio. Make up to three selections, then save. Partner With Us. You can manage and withdraw your consent at any time using our cookie consent tool found here in Cookie Settings. Show more Opinion link Opinion. These cookies ensure basic functionalities and security features of the website, anonymously. Price USD 0. Clinical Trials. Add to Your Watchlists New watchlist. Show more Tech link Tech.